Folic acid - Vitamin and panacea or genetic time bomb?

Nature Reviews Genetics

Volumn 6, Issue 3, 2005, Pages 235-240

  Lucock, Mark ^a   Yates, Zoë ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; TRACE ELEMENT; VITAMIN;

ALLELE; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE PREDISPOSITION; FOOD PREFERENCE; FOOD QUALITY; FUNCTIONAL FOOD; GENE FREQUENCY; GENETIC SELECTION; GENETIC SELECTION PRESSURE; GERIATRIC DISORDER; HUMAN; OVERNUTRITION; PRIORITY JOURNAL; REVIEW; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

DIETARY SUPPLEMENTS; FOLIC ACID; FOOD, FORTIFIED; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; SELECTION (GENETICS);

PANACEA;

EID: 14344254781     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrg1558     Document Type: Review

References (66)

1. Gillies, P. J. Nutrigenomics: the Rubicon of molecular nutrition. J. Am. Diet. Assoc. 103, S50-S55 (2003).
2. Muller, M. & Kersten, S. Nutrigenomics: goals and strategies. Nature Rev. Genet. 4, 315-322 (2003).
3. Kaput, J. Diet-disease gene interactions. Nutrition 20, 26-31 (2004).
4. Lucock, M. Is folic acid the ultimate functional food component for disease prevention? BMJ 328, 211-214 (2004).
5. Godfrey, P. S. A. et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336, 392-395 (1990).
6. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55, 1449-1455 (1998).
7. Slattery, M. L., Potter, J. D., Samowitz, W., Schaffer, D. & Leppert, M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 8, 513-518 (1999).
8. Zhang, S. et al. A prospective study of folate intake and the risk of breast cancer. JAMA 281, 1632-1637 (1999).
9. Stolzenberg-Solomon, R. Z. et al. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am. J. Epidemiol. 153, 680-687 (2001).
10. Butterworth, C. E. Folate status, women's hearth, pregnancy outcome and cancer. J. Am. Coll. Nutr. 12, 438-441 (1993).
11. 12 on squamous metaplasia of the bronchial epithelium. Cancer 71, 2477-2483 (1993).
12. Skibola, C. F. et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc. Natl Acad. Sci. USA 96, 12810-12815 (1999).
13. Boushey, C. J., Beresford, S. A., Omenn, G. S. & Motulsky, A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274, 1049-1057 (1995).
14. Medical Research Council Vitamin Study Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338, 131-137 (1991).
15. James, S. J. et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down's syndrome. Am. J. Clin. Nutr. 70, 495-501 (1999).
16. Dekker, G. A. et al. Underlying disorders associated with severe early onset preeclampsia. Am. J. Obstet. Gynecol. 173, 1042-1048 (1995).
17. Rajkovic, A., Catalano, P. M. & Malinow, M. R. Elevated homocyst(e)ine levels with preedampsia. Obstet Gynecol. 90, 168-171 (1997).
18. Roberts, D. & Schwartz, R. S. Clotting and hemorrhage in the placenta - a delicate balance. N. Engl. J. Med. 347, 57-59 (2002).
19. Wong, W. Y. et al. Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil. Steril. 77, 491-198 (2002).
20. Friso, S. & Choi, S. W. Gene-nutrient interactions and DNA methylation. J. Nutr. 132, S2382-S2387 (2002).
21. Duthie, S. J. & Hawdon, A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J. 12, 1491-1497 (1998).
22. Lucock, M. et al. A critical role for B-vitamin nutrition in human developmental and evolutionary biology. Nutr. Res. 23, 1463-1475 (2003).
23. US Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule. Fed. Regist. 61, 8781-8797 (1996).
24. Lewis, C. J., Crane, N. T., Wilson, D. B. & Yatley, E. A. Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am. J. Clin. Nutr. 70, 198-207 (1999).
25. Isotalo, P. A., Wells, G. A. & Donnelly, J. G. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am. J. Hum. Genet. 67, 986-990 (2000).
26. Munoz-Moran, E. et al. Genetic selection and folate intake during pregnancy. Lancet 352, 1120-1121 (1998).
27. Nelen, W. L., Steegers, E. A., Eskes, T. K. & Blom, H. J. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet 350, 861 (1997).
28. Gris, J. C. et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent - the Nimes Obstetricians and Haematologists Study 5 (NOHA5). Thromb. Haemost. 81, 891-899 (1999).
29. Wouters, M. G. et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil. Steril. 60, 820-825 (1993).
30. Rosenberg, N. et al. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am. J. Hum. Genet. 70, 758-762 (2002).
31. Botto, L. D. & Yang, Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital abnormalities: a HuGE review. Am. J. Epidimiol. 151, 862-877 (2000).
32. Sohn, K. J., Croxford, R., Yates, Z., Lucock, M. & Kim, Y. I. The effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J. Natl Cancer Inst. 96, 134-144 (2004).
33. Eskes, T. K. Homocysteine and human reproduction. Clin. Exp. Obstet. Gynecol. 27, 157-167 (2000).
34. Ratanasthien, K., Blair, J. A., Leeming, R. J., Cooke, W. T. & Melikian, V. Serum folates in man. J. Clin. Pathol. 30, 438-448 (1977).
35. Kelly, P., McPartlin, J., Goggins, M., Weir, D. G. & Scott, J. M. Unmetabolised folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am. J. Clin. Nutr. 65, 1790-1795 (1997).
36. Lucock, M. D., Wild, J., Smithells, R. & Hartley, R. In vivo characterisation of the absorption and biotransformation of pteroylglutamic acid in man: a model for future studies. Biochem. Med. Metab. Biol. 42, 30-42 (1989).
37. Yates, Z. & Lucock, M. Methionine synthase polymorphism A2756G is associated with susceptibility for thromboembolic events and altered B vitamin/thiol metabolism. Haematologica 87, 751-756 (2002).
38. Lucock, M. D. et al. Optimisation of Chromatographic conditions for the determination of folates in foods and biological tissues for nutritional and clinical work. Food Chem. 53, 329-338 (1995).
39. Guy, M. et al. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin. Cancer. Res. 10, 5472-5481 (2004).
40. Jablonski, N. G. & Chaplin, G. J. The evolution of human skin coloration. Hum. Evol. 39, 57-106 (2000).
41. Loomis, W. F. Skin-pigment regulation of vitamin-D biosynthesis in man. Science 157, 501-506 (1967).
42. Aoki, K. Sexual selection as a cause of human skin colour variation: Darwin's hypothesis revisited. Ann. Hum. Biol. 29, 589-608 (2002).
43. Pennisi, E. Evolution of developmental diversity: evo-devo devotees eye ocular origins and more. Science 296, 1010-1011 (2002).
44. Xu, D. X. et al. The associations among semen quality, oxidative DNA damage in human spermatozoa and concentrations of cadmium, lead and selenium in seminal plasma. Mutat. Res. 534, 155-163 (2003).
45. Davis, C. D., Uthus, E. O. & Finley, J. W. Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. J. Nutr. 130, 2903-2909 (2000).
46. El-Bayoumy, K. The protective role of selenium on genetic damage and on cancer. Mutat. Res. 475, 123-139 (2001).
47. Ma, J. et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res. 57, 1098-1102 (1997).
48. Lucock, M. D. & Yates, Z. in Folate and Human Development (ed. Massaro, E. J.) 263-298 (Humana, Totowa, New Jersey, 2001).
49. Frosst, P. et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate. Nature Genet. 10, 111-113 (1995).
50. Kang, S.-S. et al. Thermolabile methytenetetrahydrofolate reductase: an inherited risk factor for coronary heart disease. Am. J. Hum. Genet. 48, 536-545 (1991).
51. Mills, J. L. et al. Methylenetetrahydrofolate reductase thermolabile variant and oral cleft. Am. J. Med. Genet. 86, 71-74 (1999).
52. Van der Put, N. M. J. et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spinabifida. Lancet 346, 1070-1071 (1995).
53. Guenther, B. D. et al. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nature Struct. Biol. 6, 359-365 (1999).
54. Matthews, R. G. & Baugh, C. M. Interactions of pig liver methylenetetrahydrofolate reductase with methylenetetrahydropteroylpolyglutamate substrates and with dihydropteroylpolyglutamate inhibitors. Biochemistry 19, 2040-2045 (1980).
55. Lucock, M. et al. The impact of phenylketonuria on folate metabolism. Mol. Genet. Metab. 76, 305-312 (2002).
56. Hustad, S. et al. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin. Chem. 46, 1065-1071 (2002).
57. Shimakawa, T. et al. Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults. Ann. Epidemiol. 7, 285-293 (1997).
58. Jacques, P. F. et al. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J. Nutr. 132, 283-288 (2002).
59. McNulty, H. et al. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am. J. Clin. Nutr. 76, 436-441 (2002).
60. Bird, A. The essentials of DNA methylation. Cell 70, 5-8 (1992).
61. Antequera, F. & Bird, A. Number of CpG islands and genes in human and mouse. Proc. Natl Acad. Sci. USA 90, 11995-11999 (1993).
62. Bird, A., Taggart, M., Frommer, M., Miller, O. J. & Macleod, D. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 40, 91-99(1985).
63. Arlt, M. F., Casper, A. M. & Glover, T. W. Common fragile sites. Cytogenet. Genome Res. 100, 92-100 (2003).
64. Choi, S. W., Kim, Y. I., Weitzel, J. N. & Mason, J. B. Folate depletion impairs DNA excision repair in the colon of the rat, Gut 43, 93-99 (1998).
65. Gu, L., Wu, J., Oiu, L., Jennings, C. D. & Li, G. M. Involvement of DNA mismatch repair in folate deficiency-induced apoptosis. J. Nutr. Biochem. 13, 355-363 (2002).
66. Johanning, G. L. Wenstrom, K. D. & Tamura, T. Changes in frequencies of heterozygous thermolabile 5,10-methylenetetrahydrofolate reductase gene in fetuses with neural tube defects. J. Med. Genet. 39, 366-367 (2002).